Lantheus Germany GmbH clinical trials
Acquired by Lantheus Holdings, Inc., Jul 21, 2025 · source ↗
The registry lists 2 studies whose lead sponsor is Lantheus Germany GmbH. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 26, 2026.
Before and after it joined Lantheus Holdings, Inc.
- First submitted before Lantheus Germany GmbH became part of Lantheus Holdings, Inc.
- 2
- First submitted after Lantheus Germany GmbH became part of Lantheus Holdings, Inc.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Lantheus Germany GmbH2 studies
Something wrong with this grouping? Tell us on the Lantheus Holdings, Inc. page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Lantheus Holdings, Inc. studies →
- Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL AmyloidosisCompletedNCT05184088Phase 3
Sponsor listed in the registry: Lantheus Germany GmbH · First submitted before Lantheus Germany GmbH became part of Lantheus Holdings, Inc.
- Test-retest Study With [18F]FBB in Cardiac AmyloidosisCompletedNCT06790394Phase 1
Sponsor listed in the registry: Lantheus Germany GmbH · First submitted before Lantheus Germany GmbH became part of Lantheus Holdings, Inc.